Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects.
about
From Clinical Application to Cognitive Enhancement: The Example of MethylphenidatePerformance enhancement in the workplace: why and when healthy individuals should disclose their reliance on pharmaceutical cognitive enhancers.A Comparison of the Cheater Detection and the Unrelated Question Models: A Randomized Response Survey on Physical and Cognitive Doping in Recreational TriathletesSensitivity of Quantitative Signal Detection in Regards to Pharmacological NeuroenhancementUsing Caffeine Pills for Performance Enhancement. An Experimental Study on University Students' Willingness and Their Intention to Try NeuroenhancementsPharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey.(Mis)use of Prescribed Stimulants in the Medical Student Community: Motives and Behaviors: A Population-Based Cross-Sectional Study.Drugs As Instruments: Describing and Testing a Behavioral Approach to the Study of Neuroenhancement.Pharmacological Neuroenhancement: teachers' knowledge and attitudes-Results from a survey study among teachers in Germany.Alternative pharmacological strategies for adult ADHD treatment: a systematic review.Pills or Push-Ups? Effectiveness and Public Perception of Pharmacological and Non-Pharmacological Cognitive Enhancement.Alpha power oscillation in the frontal cortex under Bromazepam and Modafinil effects.Brain doping: stimulants use and misuse among a sample of Italian college students.The Complexity of Neuroenhancement and the Adoption of a Social Cognitive Perspective.The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.Limited Efficacy of Caffeine and Recovery Costs During and Following 5 Days of Chronic Sleep Restriction.Methylphenidate Enhances Early-Stage Sensory Processing and Rodent Performance of a Visual Signal Detection Task.Modafinil alters decision making based on feedback history - a randomized placebo-controlled double blind study in humans.Selected issues of the DGPPN Congress in 2013.
P2860
Q28073785-1AAB751A-469F-4D4E-A520-8A8FEE762DF0Q35120607-06B04874-95F8-490F-A352-088D4A25D043Q36027844-D187FA6B-40D8-4E32-AA01-E02C0D7A7BB1Q36244289-3EE93AB3-E573-4F6B-92FA-BEEF47EF12E9Q36559458-367D9296-15AC-4DCE-AF29-91F5011BB5A1Q36810065-7D000561-4646-4E9C-833A-CF4F527C6590Q36838005-0B6641C5-50C8-436A-B7C6-E1CDA2139D7BQ37180741-A68258C6-DBC1-478F-BCBF-90422596FFF4Q37267760-AEF86DB9-CA0D-418E-AD25-2495025AB787Q38676199-2B77D827-CFF0-41AF-8A38-0AAF9AB16AEEQ38677065-0DE2D3CD-9940-4F3A-8D22-8A1F51F3A717Q40375406-6F076FCA-C5F8-4919-AA39-6AAA7747EBB8Q41611603-4D6F903E-4D2F-4C5F-A184-1562BD433ADEQ42057840-48EA4ED4-15FE-49AE-8015-3AA9F9D897D4Q47432721-7A668543-978F-4811-9CDA-EA3F69EE2365Q47674268-6BC3225A-9233-4054-A939-C64CF887629DQ48183539-F6564D97-48D3-44BE-8435-9BCD70E27D11Q50487407-B794FE39-789A-4FB3-9264-15B89B3DD857Q50621324-7D2D23CA-7733-4FBE-BFB6-68AF52D1012A
P2860
Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Substances used and prevalence ...... cement among healthy subjects.
@en
type
label
Substances used and prevalence ...... cement among healthy subjects.
@en
prefLabel
Substances used and prevalence ...... cement among healthy subjects.
@en
P2093
P2860
P1476
Substances used and prevalence ...... cement among healthy subjects.
@en
P2093
Alice Engel
Andreas G Franke
Christiana Bagusat
Sebastian Rust
P2860
P2888
P304
P356
10.1007/S00406-014-0537-1
P478
264 Suppl 1
P50
P577
2014-09-12T00:00:00Z
P6179
1023560658